- CA$38.58m
- CA$65.88m
- CA$26.05m
- 34
- 45
- 52
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 48.4 | 45.4 | 43.3 | 27.6 | 26.1 |
Cost of Revenue | |||||
Gross Profit | 38.8 | 35.6 | 32.2 | 20.2 | 19.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 50.8 | 48.8 | 54.7 | 37.1 | 35.7 |
Operating Profit | -2.32 | -3.37 | -11.3 | -9.52 | -9.68 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -6.99 | -8.26 | -15.2 | -11.6 | -13.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.99 | -8.26 | -15.2 | -11.6 | -13.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -6.99 | -8.26 | -15.2 | -11.6 | -13.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.99 | -8.26 | -15.2 | -11.6 | -13.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.276 | -0.393 | -0.377 | -0.459 | -0.519 |